iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009

Clinical trial NCT06634628 · RECRUITING

Trial details

NCT number: NCT06634628
Sponsor: CHDI Foundation, Inc.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Huntington Disease HD PET Tracer Positron Emission Tomography Radioligand Imaging mHTT Huntington's Huntington's Disease

Start date: 2026-02-24
Primary completion: 2028-03-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.